Dataset from Non-interventional Study Describing Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)

Describe patient and physician assessed factors for patient well-being when treated with Pradaxa for stroke and embolism prevention in atrial fibrillation either compared to previous antithrombotic treatment (switcher)

本数据集描述了采用达比加群酯（Pradaxa）预防心房颤动（atrial fibrillation）患者卒中和栓塞的治疗场景中，由患者与医师共同评估的与患者健康福祉相关的影响因素，并将该治疗方案与既往抗血栓治疗（换药组，即转换治疗受试者）进行对照比较。